Bayer to Create Ag Biologicals Powerhouse Partnership with Ginkgo Bioworks
Businesswire reported that Bayer is pursuing an agreement whereby Ginkgo Bioworks will acquire Bayer’s West Sacramento Biologics Research & Development (R&D) site and internal discovery and lead optimization platform. This strategic shift to an exclusively external biologics research discovery pipeline with leading partners will activate the international open innovation ecosystem and equip Bayer to better leverage its proven capability in commercializing biologicals to create category-leading products that meet the growing need for climate-smart and sustainable options that complement traditional chemistries.
Click here to read the full article.